ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
2.370
+0.130 (5.80%)
At close: Aug 13, 2025, 4:00 PM
2.330
-0.040 (-1.69%)
Pre-market: Aug 14, 2025, 9:25 AM EDT
ProKidney Employees
ProKidney had 204 employees as of December 31, 2024. The number of employees increased by 41 or 25.15% compared to the previous year.
Employees
204
Change (1Y)
41
Growth (1Y)
25.15%
Revenue / Employee
$2,583
Profits / Employee
-$355,265
Market Cap
693.72M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 204 | 41 | 25.15% |
Dec 31, 2023 | 163 | 76 | 87.36% |
Dec 31, 2022 | 87 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PROK News
- 1 day ago - ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates - GlobeNewsWire
- 4 weeks ago - ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel - GlobeNewsWire
- 5 weeks ago - ProKidney: What's Happening With PROK Stock? - Forbes
- 5 weeks ago - ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference - GlobeNewsWire
- 5 weeks ago - ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying - Market Watch
- 5 weeks ago - Gold Falls 1%; ProKidney Shares Spike Higher - Benzinga
- 5 weeks ago - Why Is Penny Stock ProKidney Trading Higher On Tuesday? - Benzinga
- 5 weeks ago - ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes - GlobeNewsWire